Nanozyme-based catalytic theranostics

160Citations
Citations of this article
112Readers
Mendeley users who have this article in their library.

Abstract

Nanozymes, a type of nanomaterial with intrinsic enzyme-like activities, have emerged as a promising tool for disease theranostics. As a type of artificial enzyme mimic, nanozymes can overcome the shortcomings of natural enzymes, including high cost, low stability, and difficulty in storage when they are used in disease diagnosis. Moreover, the multi-enzymatic activity of nanozymes can regulate the level of reactive oxygen species (ROS) in various cells. For example, superoxide dismutase (SOD) and catalase (CAT) activity can be used to scavenge ROS, and peroxidase (POD) and oxidase (OXD) activity can be used to generate ROS. In this review, we summarize recent progress on the strategies and applications of nanozyme-based disease theranostics. In addition, we address the opportunities and challenges of nanozyme-based catalytic theranostics in the near future.

Cite

CITATION STYLE

APA

Zhang, Y., Jin, Y., Cui, H., Yan, X., & Fan, K. (2019). Nanozyme-based catalytic theranostics. RSC Advances. Royal Society of Chemistry. https://doi.org/10.1039/c9ra09021e

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free